{"id":16280,"date":"2026-06-02T11:38:28","date_gmt":"2026-06-02T08:38:28","guid":{"rendered":"https:\/\/nesiller.com\/genomic-tests-2\/"},"modified":"2026-10-20T20:23:42","modified_gmt":"2026-10-20T17:23:42","slug":"genomic-tests","status":"publish","type":"page","link":"https:\/\/nesiller.com\/en\/genomic-tests\/","title":{"rendered":"Genomic Tests"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Genomic Tests<\/div>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Intelligene WGS\/WES<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Accurate diagnosis begins with genomic tests<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tTest brochure<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tConsent Form<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tGenomic testing plays an important role in the diagnosis of rare diseases, the assessment of hereditary risk, and the development of personalized treatment approaches. With advances in Next-Generation Sequencing (NGS) technologies, Whole Genome Sequencing<\/a> (WGS), Whole Exome Sequencing (WES<\/a>), and long-read sequencing have become increasingly accessible. However, each method offers distinct advantages in terms of coverage, cost, data depth, and analytical capabilities. Selecting the most appropriate test according to the clinical or research need is critical, particularly in the context of complex genetic disorders and precision oncology<\/a> applications. The table below provides a comparative overview of the key characteristics of the different genomic testing approaches available through our laboratory.

Clinical Benefits
<\/strong>Comprehensive genomic tests used across various clinical fields, including Neurology, Pediatrics, Cardiology, Nephrology, Prenatal Genetics, and Medical Genetics, contribute to identifying the genetic causes of complex and atypical diseases and confirming diagnoses. They also provide information on disease progression and potential risks based on genetic findings. Where appropriate, the results support the development of personalized treatment and follow-up plans and help avoid unnecessary or repetitive diagnostic tests and treatments. In addition, they provide valuable information for genetic counseling regarding carrier status, hereditary risk, prenatal diagnosis, and risk assessment of family members.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our Genomic Testing Solutions:<\/strong><\/p>
\u00a0<\/th>WES<\/strong><\/th>WGS<\/strong><\/th>Long-Read Sequencing<\/strong><\/th><\/tr>
Method<\/strong><\/td>NGS (Next-Generation Sequencing) \u2013 Short-Read Sequencing<\/td>NGS (Next-Generation Sequencing) \u2013 Short-Read Sequencing<\/td>Third-Generation Sequencing \u2013 Long-Read Sequencing<\/td><\/tr>
Coverage<\/strong><\/td>~20,000 Genes<\/td>Whole Genome<\/td>Whole Exome\/Genome + Analysis of DNA\/RNA Modifications and Complex Genomic Regions<\/td><\/tr>
Applications<\/strong><\/td>\u2022 Neurodevelopmental and metabolic disorders in newborns and early childhood
\u2022 Clinical presentations suggestive of a genetic etiology based on family history but unexplained by standard genetic testing
\u2022 Adult patients with inconclusive standard genetic test results
\u2022 Rare, complex developmental and functional disorders with diagnostic challenges
\u2022 Risk assessment for familial predisposition disorders
\u2022 Personalized dietary and nutritional planning based on nutrigenomic information
\u2022 Personalized treatment planning based on pharmacogenomic information (treatment-specific efficacy and adverse effect assessment)<\/td>		\u2022 Rare and undiagnosed diseases
\u2022 Prenatal genetic investigations
\u2022 Pediatric genetic disorders
\u2022 Multisystem clinical presentations
\u2022 Cases with suspected hereditary disorders
\u2022 Suspected mitochondrial diseases and personalized health management applications<\/td>		\u2022 Clinical presentations unexplained by standard genetic testing, WES, or short-read WGS analyses
\u2022 Disorders suspected to involve large DNA alterations and chromosomal rearrangements
\u2022 Neurological diseases associated with repeat expansion disorders
\u2022 Complex genomic rearrangements, rare and undiagnosed genetic diseases
\u2022 Pseudogene-associated disorders
\u2022 Suspected mitochondrial diseases
\u2022 Advanced prenatal genomic investigations
\u2022 Pediatric genetic disorders
\u2022 Cases requiring advanced genomic characterization<\/td><\/tr>
Analytical Capabilities<\/strong><\/td>Analysis of SNVs, InDels, CNVs, and mitochondrial DNA variants<\/td>Analysis of SNVs, InDels, CNVs, and mitochondrial DNA variants<\/td>Analysis of SNVs, InDels, CNVs, STRs, translocations, pseudogene regions, mitochondrial DNA variants, methylation, and epigenetic alterations<\/td><\/tr>
Key Feature<\/strong><\/td>Analysis of coding regions with variant classification (Pathogenic \/ VUS \/ Benign)<\/td>Analysis of coding and non-coding regions<\/td>Analysis of complex genomic regions, epigenetic alterations, and transcriptomic regions<\/td><\/tr>
Sample Requirements<\/strong><\/td>EDTA Blood
Amniotic Fluid
CVS
Buccal Swab<\/td>		EDTA Blood
Amniotic Fluid
CVS
Buccal Swab<\/td>		EDTA Blood
Amniotic Fluid
CVS
Buccal Swab<\/td><\/tr>
Turnaround Time<\/strong><\/td>4\u20135 Weeks<\/td>4\u20135 Weeks<\/td>4\u20136 Weeks<\/td><\/tr><\/tbody><\/table>

* Intelligene is a trademark of Nesiller Genetic Diagnosis and Information Services Inc.
** Analysis of mitochondrial DNA provides valuable insights for the diagnosis of neurological, muscular, and metabolic disorders.
*** Please contact us for sample submission requirements.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Nesiller Genetics genomic tests (IntelliGene WGS, WES and long-read sequencing) support rare disease diagnosis, hereditary risk assessment and personalized treatment with next-generation sequencing, compared by coverage, data depth and analytical capability.<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-16280","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16280","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/comments?post=16280"}],"version-history":[{"count":37,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16280\/revisions"}],"predecessor-version":[{"id":21718,"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/pages\/16280\/revisions\/21718"}],"wp:attachment":[{"href":"https:\/\/nesiller.com\/en\/wp-json\/wp\/v2\/media?parent=16280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}